Sinovac Biotech Valuation

Sinovac Biotech current Real Value cannot be determined due to lack of data. The regular price of Sinovac Biotech is $0.0. Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. This module measures value of Sinovac Biotech from inspecting the company fundamentals such as Shares Outstanding of 57.02M, Return On Equity of 11.53% and Operating Margin of 16.19% as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
Horizon     30 Days    Login   to change
Sinovac Biotech Ltd is rated third in price to sales category among related companies. It is rated third in price to book category among related companies fabricating about  0.98  of Price to Book per Price to Sales. The ratio of Price to Sales to Price to Book for Sinovac Biotech Ltd is roughly  1.02 

Valuation Basics

Sinovac Biotech Enterprise Value Fundamentals

Quick Ratio4.43
Earnings Quarterly Growth-78.60%
Revenue Growth-22.80%
Enterprise Value To Ebitda10.67
Earnings Growth-92.90%
Enterprise Value To Revenue1.96
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
See also World Market Map. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Search macroaxis.com